Evidence map›Paper›PMID 38019806›Full record

ArticleThe Journal of infectious diseases2024

Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions.

Jesse O'Shea, Jason Zucker, Samuel Stampfer, Shama Cash-Goldwasser, Faisal S Minhaj, Alexandra Dretler, Justin Cheeley, Shaoli Chaudhuri, Stephanie M Gallitano, Shauna Gunaratne and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Fatal Mpox Coinfection in Advanced AIDS: A Case Report.Infection and drug resistance · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Jesse O'SheaMpox Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-7292-8834
Jason ZuckerDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0001-6987-6412
Samuel StampferDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Shama Cash-GoldwasserMpox Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Faisal S MinhajMpox Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alexandra DretlerDivision of Infectious Diseases, Atlanta and Emory Decatur Hospital, Decatur, Georgia.
Justin CheeleyDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Shaoli ChaudhuriDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York.
Stephanie M GallitanoDepartment of Dermatology, Columbia University Irving Medical Center, New York, New York.
Shauna GunaratneDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York.
Melissa ParkinsonDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York.
Brian EplingHIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-7434-942X
David R MorcockAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Irini SeretiHIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Claire DeleageAIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland.
Columbia University Irving Medical Center · USCenters for Disease Control and Prevention · USEmory University · USFrederick National Laboratory for Cancer Research · USNational Institutes of Health · US

Funding

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Columbia Collaborative HIV/AIDS Clinical Trials UnitU01AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HAMMER, SCOTT M · 2007 to 2011
$15.4M
Columbia Integrated Training Program in Infectious Diseases ResearchT32AI100852 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK, Anne-Catrin Uhlemann · 2013 to 2026
$2.2M
Intramural CDC HHS CC999999NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INIAID NIH HHS T32 AI100852NIAID NIH HHS U01 AI069470NIAID NIH HHS UM1 AI069470NIH HHS 775N91019D00024
6 · The paper itself

Abstract

We report 3 complicated and prolonged cases of mpox in people with advanced human immunodeficiency virus (HIV) not on antiretroviral therapy (ART) at mpox diagnosis. Multiple medical countermeasures were used, including prolonged tecovirimat treatment and immune optimization with ART initiation. Immunofluorescence of skin biopsies demonstrated a dense immune infiltrate of predominantly myeloid and CD8+ T cells, with a strong type I interferon local response. RNAscope detected abundant replication of monkeypox virus (MPXV) in epithelial cells and dendritic cells. These data suggest that prolonged mpox in people with advanced HIV may be due to ongoing MPXV replication, warranting aggressive medical countermeasures and immune optimization.

Indexed as

HIV InfectionsMpox, MonkeypoxSkin DiseasesBenzamidesHIVHumansBenzamidesAIDSHIVmonkeypox virusmpoxorthopoxvirus

Identifiers

PMID38019806
PMCPMC10965209
OpenAlexW4389130210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.